SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-051460
Filing Date
2020-11-05
Accepted
2020-11-05 17:07:42
Documents
91
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-10q_20200930.htm 10-Q 4842974
2 EX-10.3 bbio-ex103_81.htm EX-10.3 73322
3 EX-31.1 bbio-ex311_8.htm EX-31.1 22098
4 EX-31.2 bbio-ex312_7.htm EX-31.2 22143
5 EX-32.1 bbio-ex321_6.htm EX-32.1 11924
6 EX-32.2 bbio-ex322_9.htm EX-32.2 11592
  Complete submission text file 0001564590-20-051460.txt   19266721

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bbio-20200930.xml EX-101.INS 5145713
8 XBRL TAXONOMY EXTENSION SCHEMA bbio-20200930.xsd EX-101.SCH 110155
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bbio-20200930_cal.xml EX-101.CAL 84448
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bbio-20200930_def.xml EX-101.DEF 459031
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bbio-20200930_lab.xml EX-101.LAB 761541
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bbio-20200930_pre.xml EX-101.PRE 667835
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 201291481
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences